Stevanato Group Spa(STVN) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 34.14 | EPS (ttm) | 0.58 | Insider Own | 82.08% | Shs Outstand | 49.8M | Perf Week | 3.31% |
| Market Cap | 5.36B | Forward P/E | 24.17 | EPS next Y | 19.64% | Insider Trans | -0.01% | Shs Float | 48.9M | Perf Month | -8.27% |
| Enterprise Value | 5.78B | PEG | 1.43 | EPS next Q | 0.18 | Inst Own | 17.32% | Short Float | 1.97% | Perf Quarter | -3.77% |
| Income | 0.16B | P/S | 3.75 | EPS this Y | 13.06% | Inst Trans | -0.04% | Short Ratio | 2.46 | Perf Half Y | 21.16% |
| Sales | 1.43B | P/B | 3.03 | EPS next 5Y | 16.86% | ROA | 5.46% | Short Interest | 0.97M | Perf YTD | -2.39% |
| Book/sh | 6.49 | P/C | 59.64 | EPS past 3/5Y | 0.64% 11.33% | ROE | 9.2% | 52W High | -27.26% ($27.00) | Perf Year | -24.4% |
| Cash/sh | 0.33 | P/FCF | - | Sales past 3/5Y | 9% 12.15% | ROIC | 7.35% | 52W Low | 52.37% ($12.89) | Perf 3Y | -31.62% |
| Dividend Est. | $0.04 (0.19%) | EV/EBITDA | 16.63 | EPS Y/Y TTM | 7.43% | Gross Margin | 28.29% | Volatility(W/M) | 3.85% 3.47% | Perf 5Y | -21.94% |
| Dividend TTM | 0.06 | EV/Sales | 4.04 | Sales Y/Y TTM | 14.73% | Oper. Margin | 16.65% | ATR (14) | 0.71 | Perf 10Y | - |
| Dividend Ex-Date | 2026/6/11 | Quick Ratio | 1.08 | EPS Q/Q | -20.75% | Profit Margin | 10.99% | RSI (14) | 46.7 | Recom | 1.71 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.61 | Sales Q/Q | 10.63% | SMA20 | 0.6% ($19.52) | Beta | 0.8 | Target Price | $24.89 |
| Payout | 10.76% | Debt/Eq | 0.29 | Earnings | 2026/11/3 | SMA50 | -5.13% ($20.7) | Rel Volume | 0.64 | Prev Close | $19.88 |
| Employees | - | LT Debt/Eq | 0.21 | EPS/Sales Surpr. | 11.72% 2.18% | SMA200 | 8.43% ($18.11) | Avg Volume(3M) | 0.39M | Price | $19.64 |
| IPO | 2021/7/16 | Option/Short | Yes/Yes | Trades | 2114 | Volume | 250,534 | Change | -1.21% |
💉 This Italian company manufactures glass containers and drug delivery systems for the pharmaceutical and biotech industries. It supplies pharmaceutical firms with glass containers such as vials, syringes, and cartridges, as well as drug delivery devices including prefilled syringes and injection pens. As a medical device stock, its performance is closely tied to pharmaceutical production and injectable drug demand.
Over the past 1 year, roughly in the middle
27% below its 1-year high.
Traded less than usual. That is 64% of its average volume.
Next earnings report: November 3
6 days to go.
STVN makes money exceptionally well
Of every $100 in sales, $16.65 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +13.1% this year.
Tap to view numbers
The price is about the industry average
For a company earning $100 a year, you would pay $3,414. Peers typically go for $3,200.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -21.9%. The S&P 500 did +70% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 0.19% annually in dividends.
Tap to view numbers
Ownership is about average
Institutions hold 17.3%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #17 of 51 in the industry
Based on market cap of $5B.
BLCO#14 Bausch + Lomb Corp $6B PER - 
TFX#15 Teleflex Incorporated $6B PER - 
MMSI#16 Merit Medical Systems Inc $6B PER 38.5 STVN#17 Stevanato Group Spa $5B PER 34.1 
MMED#18 MiniMed Group Inc $5B PER - 
FAQ
What kind of company is STVN?
STVN belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of STVN?
The market cap of STVN is approximately $5.4B, ranking 1,319 within its sector.
Does STVN pay dividends?
STVN has a dividend yield of approximately 0.19%, with an annual dividend of $0.04.
What is the P/E ratio of STVN?
STVN has a P/E ratio of approximately 34.1x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for STVN?
STVN has recorded a 52-week high of $27.00 and a low of $12.89.
